60 Degrees Pharmaceuticals, Inc.
SXTP
$1.75
-$0.11-5.91%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 17.82% | -13.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.82% | -13.96% | |||
| Cost of Revenue | -66.98% | 691.08% | |||
| Gross Profit | 70.46% | -1,092.67% | |||
| SG&A Expenses | 7.57% | 5.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -47.46% | 191.95% | |||
| Operating Income | 49.42% | -214.55% | |||
| Income Before Tax | 48.24% | -1,075.19% | |||
| Income Tax Expenses | -25.00% | 300.00% | |||
| Earnings from Continuing Operations | 48.24% | -1,075.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -53.33% | -40.00% | |||
| Net Income | 48.24% | -1,069.29% | |||
| EBIT | 49.42% | -214.55% | |||
| EBITDA | 49.64% | -215.77% | |||
| EPS Basic | 77.96% | -1,241.19% | |||
| Normalized Basic EPS | 78.50% | -902.88% | |||
| EPS Diluted | 77.96% | -1,241.19% | |||
| Normalized Diluted EPS | 78.50% | -902.88% | |||
| Average Basic Shares Outstanding | 140.76% | 20.28% | |||
| Average Diluted Shares Outstanding | 140.76% | 20.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
